StockData
Puma Biotechnology, Inc. logo

Puma Biotechnology, Inc. (PBYI) stock

PBYINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 14/3019% below fair value
$7.22+0.08 (+1.12%)

Close on Nov 18, 2026Market cap $372.70MP/E 13.9Yield –

Puma Biotechnology profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Puma Biotechnology's profit margin for the twelve months ending Jun 30, 2026 was 11.6%. For fiscal 2025 it was 13.6%, against 13.1% the year before. The highest annual figure on record is 13.6% in fiscal 2025.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202513.6%+0.5
FY2024Dec 31, 202413.1%+4.0
FY2023Dec 31, 20239.2%+9.2
FY2022Dec 31, 20220.0%+11.5
FY2021Dec 31, 2021-11.5%+15.1
FY2020Dec 31, 2020-26.7%+1.1
FY2019Dec 31, 2019-27.8%+17.5
FY2018Dec 31, 2018-45.3%+1009.3
FY2017Dec 31, 2017-1054.6%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202614.5%+3.3
Q1 FY2026Mar 31, 2026-8.4%−14.8
Q4 FY2025Dec 31, 202517.8%−14.9
Q3 FY2025Sep 30, 202516.2%−9.0
Q2 FY2025Jun 30, 202511.2%+20.8
Q1 FY2025Mar 31, 20256.5%+17.5
Q4 FY2024Dec 31, 202432.7%+15.7
Q3 FY2024Sep 30, 202425.2%+14.9
Q2 FY2024Jun 30, 2024-9.6%−13.5
Q1 FY2024Mar 31, 2024-11.0%−13.7
Q4 FY2023Dec 31, 202317.0%+25.5
Q3 FY2023Sep 30, 202310.3%+11.0
Q2 FY2023Jun 30, 20233.9%−11.8
Q1 FY2023Mar 31, 20232.7%+10.1
Q4 FY2022Dec 31, 2022-8.5%−16.2
Q3 FY2022Sep 30, 2022-0.6%+96.0
Q2 FY2022Jun 30, 202215.7%+25.3
Q1 FY2022Mar 31, 2022-7.4%−24.3
Q4 FY2021Dec 31, 20217.6%+36.2
Q3 FY2021Sep 30, 2021-96.6%−34.6
Q2 FY2021Jun 30, 2021-9.6%−14.4
Q1 FY2021Mar 31, 202116.8%+49.9
Q4 FY2020Dec 31, 2020-28.5%−10.7
Q3 FY2020Sep 30, 2020-62.0%−32.0
Q2 FY2020Jun 30, 20204.8%+74.2
Q1 FY2020Mar 31, 2020-33.1%−22.9
Q4 FY2019Dec 31, 2019-17.8%+25.4
Q3 FY2019Sep 30, 2019-30.0%−7.3
Q2 FY2019Jun 30, 2019-69.4%+17.9
Q1 FY2019Mar 31, 2019-10.2%+26.4
Q4 FY2018Dec 31, 2018-43.2%+253.4
Q3 FY2018Sep 30, 2018-22.7%+1247.4
Q2 FY2018Jun 30, 2018-87.3%–
Q1 FY2018Mar 31, 2018-36.6%–
Q4 FY2017Dec 31, 2017-296.5%–
Q3 FY2017Sep 30, 2017-1270.0%–

More Puma Biotechnology figures

See a number that looks wrong?